<unk>  has not been shown to be safe or effective in persons 6 years to 18 years of age. Use of<unk>  by persons under the age of 6 poses a serious dehydration risk and studies have demonstrated<unk>  can cause death in juvenile mice due to this dehydrating effect. Use of<unk>  is also contraindicated in persons who are suspected of having a mechanical gastrointestinal obstruction.
Plecanatide
Eptifibatide
Sulfatide
Tirzepatide
Defibrotide
Oprelvekin
Drotrecogin alfa
Epitiostanol